Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Marco Danova

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Physiology

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gobbi Paolo G; Valentino Francesco; Danova Marco; Morabito Fortunato; Rovati Bianca; Mammi Caterina; Gentile Massimo; Merli Francesco; Stelitano Caterina; Luminari Stefano; Quintana Gianni; Iannitto Emilio; Brugiatelli Maura; Federico Massimo
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
Porta Camillo; Bonomi Lucia; Lillaz Beatrice; Klersy Catherine; Imarisio Ilaria; Paglino Chiara; Rovati Bianca; Danova Marco; Ferraris Elisa; Mensi Mario; Rovereto Bruno
Immunological stress in kidney cancer patients undergoing either open nephrectomy or nephron-sparing surgery: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Invernizzi Rosangela; Grasso Donatella; Travaglino Erica; Benatti Chiara; Collovà Elena; Manzoni Mariangela; Livraghi Luca; Danova Marco; Riccardi Alberto
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Marco Danova (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gobbi Paolo G; Valentino Francesco; Danova Marco; Morabito Fortunato; Rovati Bianca; Mammi Caterina; Gentile Massimo; Merli Francesco; Stelitano Caterina; Luminari Stefano; Quintana Gianni; Iannitto Emilio; Brugiatelli Maura; Federico Massimo
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
Oncology reports 2009;21(4):1029-35.
2008: Porta Camillo; Bonomi Lucia; Lillaz Beatrice; Klersy Catherine; Imarisio Ilaria; Paglino Chiara; Rovati Bianca; Danova Marco; Ferraris Elisa; Mensi Mario; Rovereto Bruno
Immunological stress in kidney cancer patients undergoing either open nephrectomy or nephron-sparing surgery: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Oncology reports 2008;20(6):1511-9.
2008: Invernizzi Rosangela; Grasso Donatella; Travaglino Erica; Benatti Chiara; Collovà Elena; Manzoni Mariangela; Livraghi Luca; Danova Marco; Riccardi Alberto
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy.
Oncology 2008;75(3-4):237-44.
2007: Danova Marco; Bencardino Katia; Manzoni Mariangela; Grasso Donatella; Mariucci Sara; Rovati Bianca
In vivo biological effects of pegfilgrastim after myelosuppressive chemotherapy in breast cancer.
Anticancer research 2007;27(5A):3399-402.
2007: Manzoni M; Bencardino K; Piovella F; Chatzileontiadou S; Delfanti S; Riccardi A; Danova M; Corazza G R
New agents in medical oncology and the risk of venous thromboembolism.
Journal of experimental & clinical cancer research : CR 2007;26(2):185-94.
2007: Bencardino K; Manzoni M; Delfanti S; Riccardi A; Danova M; Corazza G R
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues.
Internal and emergency medicine 2007;2(1):3-12.
2007: Porta Camillo; Bonomi Lucia; Lillaz Beatrice; Paglino Chiara; Rovati Bianca; Imarisio Ilaria; Morbini Patrizia; Villa Chiara; Danova Marco; Mensi Mario; Rovereto Bruno
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Anticancer research 2007;27(1A):165-73.
2006: Palmeri Sergio; Lorusso Vito; Palmeri Laura; Vaglica Marina; Porta Camillo; Nortilli Rolando; Ferraú Francesco; Comella Giuseppe; Massidda Bruno; Danova Marco;
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
Cancer 2006;107(12):2898-905.
2006: Marangolo Maurizio; Bengala Carmelo; Conte Pier Franco; Danova Marco; Pronzato Paolo; Rosti Giovanni; Sagrada Paola
Dose and outcome: the hurdle of neutropenia (Review).
Oncology reports 2006;16(2):233-48.
2006: Invernizzi Roberta; Bencardino Katia; Porta Camillo; Vercelli Alessandro; Viglio Alessandra; Manzoni Mariangela; Sagrada Paola; Danova Marco
Sigmoid colon metastasis from sarcomatoid renal cell carcinoma.
Tumori 2006;92(3):246-8.
2006: Bengala C; Zamagni C; Pedrazzoli P; Matteucci P; Ballestrero A; Da Prada G; Martino M; Rosti G; Danova M; Bregni M; Jovic G; Guarneri V; Maur M; Conte P F;
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study.
British journal of cancer 2006;94(7):1016-20.
2006: Semino Alessandra; Danova Marco; Perlini Stefano; Palladini Giovanni; Riccardi Alberto; Perfetti Vittorio
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult.
American journal of clinical oncology 2006;29(1):102-3.
2006: Riccardi Alberto; Brugnatelli Silvia; Danova Marco; Giordano Monica; Pugliese Palma; Luchena Giovanna; Grasso Donatella; Trotti Giovanni; Bertè Raffaella; Pansini Giovanni; Tinelli Carmine
Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.
Tumori 2006;92(1):6-12.
2005: Danova Marco; Rosti Giovanni; De Placido Sabino; Bencardino Katia; Venturini Marco
Use of granulocyte colony-stimulating factor: a survey among Italian medical oncologists.
Oncology reports 2005;14(6):1405-12.
2005: Ferrari Silvia; Malugani Fabio; Rovati Bianca; Porta Camillo; Riccardi Alberto; Danova Marco
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Oncology reports 2005;14(1):113-20.
2005: Porta Camillo; Imarisio Ilaria; De Amici Mara; Bonomi Lucia; Paglino Chiara; Biscaldi Elisa; Zimatore Matteo; Sartore-Bianchi Andrea; Danova Marco; Moratti Remigio; Riccardi Alberto
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients.
Oncology reports 2005;13(4):689-95.
2005: Palmeri S; Vaglica M; Spada S; Filippelli G; Farris A; Palmeri L; Massidda B; Misino A; Ferraù F; Comella G; Leonardi V; Condemi G; Mangiameli A; De Cataldis G; Macaluso M C; Cajozzo M; Iannitto E; Danova M
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
Oncology 2005;68(4-6):438-45.
2005: Della Porta Matteo; Danova Marco; Rigolin Gian Matteo; Brugnatelli Silvia; Rovati Bianca; Tronconi Chiara; Fraulini Chiara; Russo Rossi Antonella; Riccardi Alberto; Castoldi Gianluigi
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings.
Oncology 2005;68(2-3):276-84.
2004: Porta Camillo; Zimatore Matteo; Imarisio Ilaria; Natalizi Anna; Sartore-Bianchi Andrea; Danova Marco; Riccardi Alberto
Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II study.
Cancer 2004;100(10):2132-8.
2004: Porta C; Caporali R; Epis O; Ramaioli I; Invernizzi R; Rovati B; Comolli G; Danova M; Montecucco C
Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation.
Bone marrow transplantation 2004;33(7):721-8.
2003: Ballestrero Alberto; Montemurro Filippo; Gonella Roberta; Capaldi Antonio; Danova Marco; Friedman Daniele; Puglisi Maria; Aglietta Massimo; Patrone Franco
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability.
Breast cancer research and treatment 2003;82(3):185-90.
2003: Lucioni M; Boveri E; Rosso R; Benazzo M; Necchi V; Danova M; Incardona P; Franco C; Viglio A; Riboni R; Lazzarino M; Magrini U; Canevari A; Paulli M
Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case study.
Histopathology 2003;43(6):583-91.
2003: Ferrari Silvia; Rovati Bianca; Porta Camillo; Alessandrino Paolo Emilio; Bertolini Alessandro; Collovà Elena; Riccardi Alberto; Danova Marco
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
Cancer immunology, immunotherapy : CII 2003;52(6):359-66.
2003: Riccardi Alberto; Grasso Donatella; Danova Marco
Bisphosphonates in oncology: physiopathologic bases and clinical activity.
Tumori 2003;89(3):223-36.
2003: Riccardi A; Mora O; Tinelli C; Porta C; Danova M; Brugnatelli S; Grasso D; Tolcà B; Spanedda R; De Paoli A; Barbarano L; Cavanna L; Giordano M; Delfini C; Nicoletti G; Bergonzi C; Rinaldi E; Piccinini L; Ascari E
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.
European journal of cancer (Oxford, England : 1990) 2003;39(1):31-7.
2002: Malugani Fabio; Danova Marco
[Utilization of hemopoietic cytokines]
Tumori 2002;88(6):A13-20.
2002: Porta Camillo; Rizzo Vittoria; Zimatore Matteo; Sartore-Bianchi Andrea; Danova Marco; Mutti Luciano
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity?
Lung cancer (Amsterdam, Netherlands) 2002;38(2):159-62.
2002: Ferrari Silvia; Rovati Bianca; Cucca Lucia; Scarabelli Claudio; Presti Mauro; Beccaria Cristina; Collovà Elena; Porta Camillo; Danova Marco
Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
Oncology reports 2002;9(5):1107-13.
2002: Zimatore Matteo; Danova Marco; Vassallo Erasmo; Porta Camillo; Macaluso Maria Catena; Schittone Loredana; Riccardi Alberto; Palmeri Sergio
Weekly taxanes in metastatic breast cancer (review).
Oncology reports 2002;9(5):1047-52.
2002: Ferrari S; Danova M; Porta C; Brugnatelli S; Pugliese P; Bertolini A; Riccardi A
Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation.
Annals of hematology 2002;81(6):354-6.
2002: Brugnatelli Silvia; Danova Marco; De Bella Manuela Tamburo; Vaglica Marina; Manuguerra Giovanna; Riccardi Alberto; Palmeri Sergio
Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
Oncology 2002;62(1):33-8.
2001: Danova M; Porta C; Ferrari S; Riccardi A
Strategies of medical treatment for metastatic breast cancer (Review).
International journal of oncology 2001;19(4):733-9.
2001: Riccardi A; Pugliese P; Danova M; Brugnatelli S; Grasso D; Giordano M; Bernardo G; Giardina G; Fava S; Montanari G; Pedrotti C; Trotti G; Rinaldi E; Poli M A; Tinelli C
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01).
British journal of cancer 2001;85(2):141-6.
2001: Brugnatelli S; Riccardi A; Danova M; Pugliese P; Tinelli C; Luchena G; Bernardo A; Giardina G; Fava S; Montanari G; Pedrotti C; Poli A M
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study.
Oncology reports 2001;8(4):801-5.
2001: Porta C; Danova M; Accurso S; Tinelli C; Girino M; Riccardi A; Palmeri S
Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study.
Cancer chemotherapy and pharmacology 2001;47(5):423-8.
2001: Danova M; Girino M; Riccardi A
[Phenotypic markers in colorectal cancer]
Tumori 2001;87(1 Suppl 1):S76.
2000: Danova M; Aglietta M; Pierelli L; Ferrari S; Perillo A; Scambia G; Henry D
[The use of erythropoietin alpha in programs of high-dose chemotherapy]
Recenti progressi in medicina 2000;91(12):681-9.
2000: Rosti V; Malabarba L; Ramajoli I; Casula S; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Salvaneschi L; Cazzola M
Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle.
Haematologica 2000;85(11 Suppl):18-25.
2000: Porta C; Danova M; Orengo A M; Ferrini S; Moroni M; Gaggero A; Libener R; Betta P G; Ferrari S; Procopio A; Strizzi L; Mutti L
Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro.
Journal of cellular physiology 2000;185(1):126-34.
2000: Balloni L; Porta C; Rossi S; Gola A; Pugliese P; Ferrari S; Bovio A; Danova M; Riccardi A
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy: an echocardiographic study.
Oncology reports 2000;7(4):887-90.
2000: Pugliese P; Danova M; Brugnatelli S; Piccolo G; Riccardi A; Ascari E
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer.
Haematologica 2000;85(6):672.
2000: Danova M; Porta C; Ferrari S; Brugnatelli S; Comolli G; Riccardi A; Ascari E
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patients.
Oncology reports 2000;7(3):585-9.
2000: Riccardi A; Tinelli C; Brugnatelli S; Pugliese P; Giardina V; Giordano M; Danova M; Richetti A; Fava S; Rinaldi E; Fregoni V; Trotti G; Poli A
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer.
International journal of oncology 2000;16(4):769-76.
2000: Lucotti C; Malabarba L; Rosti V; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Ramajoli I; Perotti C; Torretta L; De Amici M; Salvaneschi L; Cazzola M
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle.
British journal of haematology 2000;108(3):621-8.
2000: Balloni L; Pugliese P; Ferrari S; Danova M; Porta C
Colon cancer in pregnancy: report of a case and review of the literature.
Tumori 2000;86(1):95-7.
1999: Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Haematologica 1999;84(11):1016-23.
1999: Ferrari S; Danova M; Porta C; Comolli G; Brugnatelli S; Pugliese P; Riccardi A; Ascari E
Circulating progenitor cell release and functional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients.
International journal of oncology 1999;15(4):811-5.
1999: Porta C; Danova M; Riccardi A; Bobbio-Pallavicini E; Ascari E
Cancer chemotherapy-related thrombotic thrombocytopenic purpura: biological evidence of increased nitric oxide production.
Mayo Clinic proceedings. Mayo Clinic 1999;74(6):570-4.
1998: Leonardi V; Danova M; Fincato G; Palmeri S
Interleukin 3 in the treatment of chemotherapy induced thrombocytopenia.
Oncology reports 1998;5(6):1459-64.
1998: Riccardi A; Brugnatelli S; Giordano M; Danova M; Pugliese P; Tinelli C; Klersy C; Richetti A; Fava S; Nastasi G; Rinaldi E; Fregoni V; De Monte A; Trotti G; Bovio A; Ascari E
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer.
Tumori 1998;84(5):540-6.
1998: Pugliese P; Brugnatelli S; Giordano M; Danova M; De Monte A; Richetti A; Fava S; Rinaldi E; Fregoni V; Epifani C; Riccardi A
Paclitaxel in anthracycline-treated breast cancer patients.
Oncology reports 1998;5(4):915-8.
1998: Mangiarotti R; Bottone M G; Danova M; Pellicciari C
Bivariate flow cytometric analysis of DNA content versus immunopositivity for ribonucleotide reductase M1 subunit in the cell cycle.
Cytometry 1998;32(2):78-85.
1998: Danova M; Perotti C; Mora O; Lucotti C; Torretta L; Comolli G; Riccardi A; Salvaneschi L; Ascari E
Multicyclic dose-intensive chemotherapy with circulating progenitor cell support for high-risk primary breast cancer.
Oncology reports 1998;5(2):427-9.
1998: Antognoni P; Terry NHA; Richetti A; Luraghi R; Tordiglione M; Danova M
The predictive role of flow cytometry-derived tumor potential doubling time (Tpot) in radiotherapy: open questions and future perspectives.
International journal of oncology 1998;12(2):245-56.
1998: Palmeri S; Meli M; Danova M; Bernardo G; Leonardi V; Dastoli G; Rausa L; Russo A; Filippelli G; Palmieri G; Russo A; Della Vittoria Scarpati M; Lo Russo V; Di Lauro L; Colucci G; Bruni G; Piazzi M; Gebbia N; Spada S
5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
Journal of cancer research and clinical oncology 1998;124(3-4):191-8.
1998: Mangiarotti R; Danova M; Alberici R; Pellicciari C
All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells.
British journal of cancer 1998;77(2):186-91.
1997: Danova M; Aglietta M
Cytokine receptors, growth factors and cell cycle in human bone marrow and peripheral blood hematopoietic progenitors.
Haematologica 1997;82(5):622-9.
1997: Visani G; Ottaviani E; Danova M; Mangiarotti R; Tosi P; Tura S
The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 15 refractory cases.
Haematologica 1997;82(3):338-40.
1997: Mangiarotti R; Danova M; Alberici R; Pellicciari C
Cell cycle kinetic effects and induction of apoptosis by all-trans retinoic acid (ATRA) in human MCF-7 breast cancer cells.
European journal of histochemistry : EJH 1997;41 Suppl 2():77-8.
1996: Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie M J; Merlini G; Cazzola M
Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
British journal of haematology 1996;93(4):789-94.
1996: Torretta L; Perotti C; Dornini G; Danova M; Locatelli F; Pedrazzoli P; Preti P; Da Prada G A; Pavesi L; Robustelli della Cuna G; Salvaneschi L
Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donors.
Haematologica 1996;81(3):208-15.
1996: Mazzini G; Danova M; Ferrari C; Giordano M; Dionigi P; Riccardi A
Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1996;10(2):101-13.
1996: Benazzo M; Bernardo G; Corbella F; Danova M; Lanza L; Zappoli F; Uggetti C; Mira E
[High-dose carboplatin superselective intraarterial chemotherapy in advanced head and neck cancer]
Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale 1996;16(1):30-4.
1995: Pellicciari C; Mangiarotti R; Bottone M G; Danova M; Wang E
Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
Cytometry 1995;21(4):329-37.
1995: Rosti V; Bergamaschi G; Lucotti C; Danova M; Carlo-Stella C; Locatelli F; Tonon L; Mazzini G; Cazzola M
Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.
Blood 1995;86(9):3387-93.
1995: Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
ORL; journal for oto-rhino-laryngology and its related specialties 1995;57(1):39-43.
1995: Riccardi A; Giordano M; Brugnatelli S; Ucci G; Danova M; Mora O; Fava S; Ascari E
Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1549-51.
1994: Casasco A; Maserati E; Giordano M; Casasco M; Ciuffreda M; Sander S; Danova M; Scappaticci S; Calligaro A; Springall D R
Stimulation of DNA synthesis by endothelin-1 in primary cultures of human dental pulp.
Archives of oral biology 1994;39(3):245-9.
1994: Casasco A; Casasco M; Cornaglia A I; Danova M; Giordano M; Calligaro A
Tissue fixation for immunohistochemical detection of proliferating cell nuclear antigen with PC10 monoclonal antibody.
Biotechnic & histochemistry : official publication of the Biological Stain Commission 1994;69(2):112-7.
1994: Bergamaschi G; Rosti V; Danova M; Lucotti C; Cazzola M
Apoptosis: biological and clinical aspects.
Haematologica 1994;79(1):86-93.
1994: Pedrazzoli P; Bacciocchi G; Bergamaschi G; Cazzola M; Danova M; Gibelli N; Giordano M; Lazzaro A; Locatelli F; Pavesi L
Effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on small cell lung cancer cells.
Cancer investigation 1994;12(3):283-8.
1993: Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M
Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(12):2012-8.
1993: Danova M; Pellicciari C; Zibera C; Mangiarotti R; Gibelli N; Giordano M; Wang E; Mazzini G; Riccardi A
Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
Annals of the New York Academy of Sciences 1993;698():174-81.
1993: Giordano M; Danova M; Mazzini G; Gobbi P; Riccardi A
Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Prognostic significance in acute nonlymphoblastic leukemia.
Cancer 1993;71(9):2739-45.
1993: Casasco A; Giordano M; Danova M; Casasco M; Icaro Cornaglia A; Calligaro A
PC10 monoclonal antibody to proliferating cell nuclear antigen as probe for cycling cell detection in developing tissues. A combined immunocytochemical and flow cytometric study.
Histochemistry 1993;99(3):191-9.
1993: Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Haematologica 1993;78(1):44-8.
1992: Ucci G; Petrini M; Riccardi A; Invernizzi R; Carulli G; Luoni R; Giordano M; Danova M
Expression of p170 protein in multiple myeloma: a clinical study.
Hematological oncology 1992;10(3-4):213-20.
1992: Bacciocchi G; Gibelli N; Zibera C; Pedrazzoli P; Bergamaschi G; De Piceis Polver P; Danova M; Mazzini G; Palomba L; Tupler R
Establishment and characterization of two cell lines derived from human glioblastoma multiforme.
Anticancer research 1992;12(3):853-61.
1991: Gaetani P; Butti G; Chiabrando C; Danova M; Castelli M G; Riccardi A; Assietti R; Paoletti P
A study on the biological behavior of human brain tumors. Part I. Arachidonic acid metabolism and DNA content.
Journal of neuro-oncology 1991;10(3):233-40.
1991: Riccardi A; Invernizzi R; Ucci G; Luoni R; Danova M; Giordano M; Zambelli M L; Rastaldi M P; Ascari E
[p170 in multiple myeloma and acute leukemia]
Haematologica 1991;76 Suppl 3():177-80.
1991: Giaretti W; Danova M; Geido E; Mazzini G; Sciallero S; Aste H; Scivetti P; Riccardi A; Marsano B; Merlo F
Flow cytometric DNA index in the prognosis of colorectal cancer.
Cancer 1991;67(7):1921-7.
1991: Riccardi A; Giordano M; Danova M; Girino M; Brugnatelli S; Ucci G; Mazzini G
Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia.
European journal of cancer (Oxford, England : 1990) 1991;27(7):882-7.
1991: Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Cancer detection and prevention 1991;15(5):391-6.
1990: Danova M; Riccardi A; Ucci G; Luoni R; Giordano M; Mazzini G
Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study.
British journal of cancer 1990;62(5):781-5.
1990: Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
Immunocytochemical evaluation of proliferative activity in human brain tumours.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1990;2(5):269-75.
1990: Danova M; Riccardi A; Mazzini G
Cell cycle-related proteins and flow cytometry.
Haematologica 1990;75(3):252-64.
1990: Assietti R; Butti G; Magrassi L; Danova M; Riccardi A; Gaetani P
Cell-kinetic characteristics of human brain tumors.
Oncology 1990;47(4):344-51.
1989: Cavalli C; Danova M; Gobbi P G; Riccardi A; Magrini U; Mazzini G; Bertoloni D; Rutigliano L; Rossi A; Ascari E
Ploidy and proliferative activity measurement by flow cytometry in non-Hodgkin's lymphomas. Do speculative aspects prevail over clinical ones?
European journal of cancer & clinical oncology 1989;25(12):1755-63.
1989: Scivetti P; Danova M; Riccardi A; Fiocca R; Dionigi P; Mazzini G
Prognostic significance of DNA content in large bowel carcinoma: a retrospective flow cytometric study.
Cancer letters 1989;46(3):213-9.
1989: Danova M; Riccardi A; Brugnatelli S; Maserati R; Comolli G; Mazzini G; Castello A; Ascari E; Rondanelli E G
Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome.
Haematologica 1989;74(4):365-9.
1989: Riccardi A; Danova M; Dionigi P; Gaetani P; Cebrelli T; Butti G; Mazzini G; Wilson G
Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.
British journal of cancer 1989;59(6):898-903.
1989: Giordano M; Danova M; Riccardi A; Mazzini G
Simultaneous detection of cellular ras p21 oncogene product and DNA content by two-parameter flow cytometry.
Anticancer research 1989;9(3):799-803.
1989: Dezza L; Cazzola M; Danova M; Carlo-Stella C; Bergamaschi G; Brugnatelli S; Invernizzi R; Mazzini G; Riccardi A; Ascari E
Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(2):104-7.
1989: Butti G; Gaetani P; Danova M; Assietti R; Girino M; Riccardi A
Cell kinetic studies of human intracranial tumors.
Journal of neurosurgical sciences 1989;33(1):47-53.
1989: Casasco A; Calligaro A; Marchetti C; Poggi P; Brugnatelli S; Danova M; Fiocca R
Immunocytochemical detection of proliferating cells in the rat tooth germ by monoclonal antibodies against 5-bromo-2'-deoxyuridine.
Archives of oral biology 1989;34(1):65-9.
1988: Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R
Early plasma cell recruitment in multiple myeloma following chemotherapy.
Cell and tissue kinetics 1988;21(6):405-9.
1988: Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally N J; Ascari E
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Cancer research 1988;48(21):6238-45.
1988: Danova M; Riccardi A; Mazzini G; Wilson G; Dionigi P; Brugnatelli S; Fiocca R; Ucci G; Jemos V; Ascari E
Flow cytometric analysis of paraffin-embedded material in human gastric cancer.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1988;10(3):200-6.
1988: Danova M; Riccardi A; Gaetani P; Wilson G D; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
European journal of cancer & clinical oncology 1988;24(5):873-80.
1988: Gaetani P; Danova M; Butti G; Silvani V; Brugnatelli S; Buttini R; Knerich R; Riccardi A
Cell kinetics aspects of human malignant neuroepithelial tumors: a follow-up study.
Tumori 1988;74(2):145-50.
1988: Danova M; Riccardi A; Brugnatelli S; Fiocca R; Girino M; Villani L; Giordano P; Dionigi P; Giordano M; Buttini R
In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections.
The Histochemical journal 1988;20(3):125-30.
1988: Riccardi A; Giordano M; Giordano P; Cassano E; Girino M; Cazzola M; Scivetti P; Danova M; Ucci G
Prognostic parameters in myelodysplastic syndromes: a multiple regression analysis.
European journal of haematology 1988;40(2):158-62.
1988: Luoni R; Ucci G; Riccardi A; Spriano P; Danova M; Cassano E; Molinari E; Ascari E
Serum thymidine kinase in hematologic malignancies.
Haematologica 1988;73(1):31-5.
1988: Danova M; Riccardi A; Giordano M; Girino M; Mazzini G; Dezza L; Ascari E
Cell cycle-related proteins: a flow cytofluorometric study in human tumors.
Biology of the cell / under the auspices of the European Cell Biology Organization 1988;64(1):23-8.
1987: Ucci G; Riccardi A; Luoni R; Spriano P; Merlini G; Danova M; Cassano E; Molinari E; Ascari E
Serum thymidine kinase and beta-2 microglobulin in monoclonal gammopathies.
Tumori 1987;73(5):445-9.
1987: Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R; Montecucco C M; Ciotti R; Girino M
Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
Cell and tissue kinetics 1987;20(3):311-8.
1987: Danova M; Wilson G; Riccardi A; Mazzini G; Ucci G; Giordano M; Brugnatelli S; Luoni R; McNally N J; Ascari E
In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignancies.
Haematologica 1987;72(2):115-9.
1987: Ucci G; Mazzini G; Caporali R; Danova M; Montecucco C M; Riccardi A
Flow cytometric determination of ploidy and proliferative activity on isolated bone marrow particles and on total bone marrow aspirate.
Basic and applied histochemistry 1987;31(1):83-90.
1987: Ucci G; Danova M; Riccardi A; Brugnatelli S; Girino M; Corridoni S; Trespi A
Abnormalities of T cell subsets in a patient with cyclic neutropenia.
Acta haematologica 1987;77(3):177-9.
1987: Danova M; Riccardi A; Mazzini G; Ucci G; Gaetani P; Silvani V; Knerich R; Butti G; Ascari E
Ploidy and proliferative activity of human brain tumors. A flow cytofluorometric study.
Oncology 1987;44(2):102-7.
1986: Riccardi A; Merlini G; Montecucco C; Danova M; Ucci G; Cassano E; Ascari E
Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma.
European journal of cancer & clinical oncology 1986;22(7):787-91.
1986: Riccardi A; Invernizzi R; Girino M; Cassano E; Giordano M; Ucci G; Danova M; Montecucco C; Bobbio-Pallavicini E; Ascari E
Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemia.
Haematologica 1986;71(2):129-33.
1986: Riccardi A; Danova M; Montecucco C; Ucci G; Cassano E; Giordano M; Mazzini G; Giordano P
Adult acute non-lymphoblastic leukaemia: reliability and prognostic significance of pretreatment bone marrow S-phase size determined by flow cytofluorometry.
Scandinavian journal of haematology 1986;36(1):11-7.
1986: Danova M; Riccardi A; Mazzini G; Ucci G; Montecucco C M; Gaetani P; Silvani V; Knerich R; Butti G; Ascari E
Proliferative characteristics and ploidy of human brain tumors by DNA flow cytometry.
Basic and applied histochemistry 1986;30(2):175-80.
1986: Montecucco C; Riccardi A; Ucci G; Danova M; Carnevale R; Caporali R; Longhi M; Luoni R
Analysis of human myeloma cell population kinetics.
Acta haematologica 1986;75(3):153-6.
1986: Riccardi A; Montecucco C M; Danova M; Ucci G; Mazzini G; Giordano P A; Pasquali F
Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias.
Basic and applied histochemistry 1986;30(2):181-92.
1985: Giordano P A; Mazzini G; Riccardi A; Montecucco C M; Ucci G; Danova M
Propidium iodide staining of cytoautoradiographic preparations for the simultaneous determination of DNA content and grain count.
The Histochemical journal 1985;17(11):1259-70.
1985: Montecucco C; Riccardi A; Mazzini G; Danova M; Ucci G; Giordano P A
DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies.
Basic and applied histochemistry 1985;29(3):275-82.
1983: Montecucco C; Riccardi A; Traversi E; Danova M; Ucci G; Mazzini G; Giordano P
Flow cytometric DNA content in myelodysplastic syndromes.
Cytometry 1983;4(3):238-43.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Marco Danova

Research Profile (preview)

Procedures

Physiology

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Marco Danova (preview)

All Publications